Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Techne, 908 Devices Partner on Protein Characterization

NEW YORK – Bio-Techne and 908 Devices said on Tuesday that they are jointly developing an extended workflow for protein characterization.

Specifically, the firms plan to pair Minneapolis-based Bio-Techne's Maurice icIEF protein separation instrument with Boston-based 908 Devices' ZipChip platform, enabling in-depth characterization of intact and near-native biotherapeutics.

908 Devices' open-access ZipChip platform enables high-resolution separation and mass spec sample introduction. It directly integrates electrospray ionization with mass spectrometry and is compatible with Thermo Fisher Scientific, Sciex, and Bruker mass spectrometers. ZipChip uses capillary electrophoresis and electrospray ionization technology to minimize sample prep burden, perform high-resolution separations, and directly introduce samples into a mass spec instrument, according to the firms.

"By partnering with Bio-Techne and leveraging their market leading Maurice icIEF platform with our ZipChip device, we are together extending the workflow for customers conducting detailed protein characterization of charge variants," said Kevin Knopp, CEO and cofounder of 908 Devices, in statement. "This collaboration helps advance our reach into the biopharmaceutical market."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more